US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,851.23

+11.870.65%

Number of Gainers:10

Number of Losers:9

Number of Flat:- -

PE:- -

High:1,856.36

Open:1,840.14

Low:1,840.14

Close:1,839.40

Volume:40.08M

Turnover:2.69B

Market Cap:1.51T

Float Cap:1.47T

Loading ...

Berenberg Bank Sticks to Their Hold Rating for Bilfinger (0NRG)

Novartis India Hits Record High After Recent Acquisition, Distribution Deal

Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors

Lakeland Industries Inc Reports Results for the Quarter Ended July 31 - Earnings Summary

Lakeland Industries Q2 Sales USD 50.1 Million Vs. IBES Estimate USD 51.4 Million

Lakeland Industries Q2 Net Sales Fall on Industrial Revenue Decline Despite Fire Products Demand

Lakeland Industries Shares Down 8% After the Bell Following Results

THOMSON REUTERS

Lakeland Industries Q2 EPS $(0.50) Misses $(0.05) Estimate, Sales $50.139M Miss $51.483M Estimate

Benzinga Earnings

Lakeland Q2 FY27 Net Loss Widens to $4.9 Million; Net Sales Fall 4.5% to $50.1 Million

Lakeland Industries Q2 Gross Profit USD 18.5 Million

THOMSON REUTERS

Lakeland Fire + Safety Reports Fiscal Second Quarter 2027 Results

THOMSON REUTERS

U.S. Earnings Preview: After Market Close Sept. 9

Opus Genetics price target raised to $16 from $13 at Chardan

TwoStep Therapeutics Raises $62.5 Million in Series a Led by Insight Partners, Medical Excellence Capital

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live

AstraZeneca Shares Look Set for Swift Recovery

AstraZeneca's COPD Drug Data to Boost Sales Outlook

RBC Initiates AstraZeneca at Outperform With GBP145 Price Target

MT Newswires Live

BMO Capital Adjusts Price Target on Pfizer to $35 From $30, Keeps Outperform Rating

MT Newswires Live

Ocugen to Share Ophthalmic Gene Therapy Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4568/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1851.2709,"timestamp":1789584128960,"preClose":1839.4017,"halted":0,"volume":40082267,"delay":0,"changeRate":0.006453,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":11.869141,"latestTime":"09-16 14:42:09 EDT","open":1840.1401,"high":1856.3588,"low":1840.1401,"amount":2694057764.076643,"amplitude":0.008817,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.813571,"peRate":46.839236,"turnoverRate":0.002889,"increases":10,"decrements":9,"flats":0,"marketCap":1505652549191,"floatMarketCap":1471385881035.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1856.3588,"amplitude":0.008817,"preClose":1839.4017,"low":1840.1401,"pbRate":"4.813571","latestPrice":1851.2269,"volume":40083902,"delay":0,"open":1840.1401,"prevYearClose":1637.1339,"prevWeekClose":1829.725,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1835.2891,"twentyDayClose":1825.2384,"sixtyDayClose":1632.7009,"secType":"PLATE","market":"US","turnoverRate":0.002889,"peRate":46.839236,"marketCap":1505652549191,"floatMarketCap":1471385881035.5,"timestamp":1789584131090,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":9,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666637725","title":"Berenberg Bank Sticks to Their Hold Rating for Bilfinger (0NRG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666637725","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666637725?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:25","pubTimestamp":1789025115,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst Andreas Wolf maintained a Hold rating on Bilfinger today and set a price target of €92.50. According to TipRanks, Wolf is ra...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-sticks-to-their-hold-rating-for-bilfinger-0nrg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-sticks-to-their-hold-rating-for-bilfinger-0nrg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNTX","BK4535","BK4588","BK4551","BK4568","BK4548","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666655750","title":"Novartis India Hits Record High After Recent Acquisition, Distribution Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2666655750","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666655750?lang=en_us&edition=fundamental","pubTime":"2026-09-10 13:29","pubTimestamp":1789018142,"startTime":"0","endTime":"0","summary":"BUZZ-Novartis India hits record high after recent acquisition, distribution deal** Pharma co Novartis India'sNOIN.BOshares rise 18% to 2,580 rupees, hitting an all-time high** Stock has gained in six of last seven trading sessions** Gains come after co on Tuesday said it entered into an exclusive promotion and distribution agreement with Novartis Healthcare to market its retina portfolio in India** On Monday, Novartis India said that it would acquire the Minipress brand and related IP from PfizerPFE.Nfor about 12.5 billion rupees ** NOIN holds trailing 12-month PE of 55.26 vs industry median of 23.98","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4N4520C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","IE0009355771.USD","LU0225284248.USD","OZEM","LU0070302665.USD","SG9999002232.USD","BK4568","LU0321505868.SGD","BK4007","BK4534","LU0306806265.USD","LU1894683348.USD","LU1057294990.SGD","LU0985481810.HKD","BK4550","LU0170899867.USD","LU1066053197.SGD","PPH","BK4581","IE00B19Z3B42.SGD","LU0211331839.USD","IE00B3T34201.USD","LU0868494617.USD","IE00BFTCPJ56.SGD","LU1883839398.USD","SG9999003800.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","BK4585","LU0058720904.USD","MEDX","IE00BLSP4239.USD","BK4599","IE000M9KFDE8.USD","PFE","SGXZ57979304.SGD","LU1066051498.USD","IE00BLSP4452.SGD","LU1894683264.USD","LU0208291251.USD","SG9999002224.SGD","BK4532","IE00B4R5TH58.HKD","LU0234572021.USD","BK4578","BK4592","SG9999001176.SGD","LU0306807586.USD","BK4533","LU0321505439.SGD","LU1023059063.AUD","SG9999013999.USD","BK4588","LU0320765489.SGD","IE00BJJMRZ35.SGD","NVS","LU0456855351.SGD","IE00B2B36J28.USD","LU0225771236.USD","IE00B19Z3581.USD","LU2596442595.SGD","IE0002141913.USD","SG9999011175.SGD","LU0122379950.USD","IE0002270589.USD","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2666558681","title":"Novavax Inc. Stock Underperforms Wednesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558681","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558681?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:27","pubTimestamp":1788989220,"startTime":"0","endTime":"0","summary":"DJ Novavax Inc. Stock Underperforms Wednesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  shed 3.34% to $9.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index  falling 0.64% to 26,253.34 and Dow Jones Industrial Average  falling 0.77% to 52,380.66.This was the stock's third consecutive day of losses.Novavax Inc. closed 17.71% short of its 52-week high of $11.97, which the company achieved on February 26th.The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson  fell 0.76% to $267.08, Pfizer Inc.  fell 0.04% to $27.78, and Merck & Co. Inc.  fell 0.63% to $147.53.Trading volume  eclipsed its 50-day average volume of 4.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 9, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4568","BK4585","NVAX","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530034","title":"Lakeland Industries Inc Reports Results for the Quarter Ended July 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530034","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530034?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:03","pubTimestamp":1788987804,"startTime":"0","endTime":"0","summary":"Lakeland Industries Inc reports results for the quarter ended July 31 - Earnings SummaryLakeland Industries IncLAKE.OQreported a quarterly adjusted loss of 37 cents per share for the quarter ended Jul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL8N4512GR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LAKE","IE00B19Z4B17.USD","IE00B7SZL793.SGD","IE0031619046.USD","BK4202","BK4568","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666014537","title":"Lakeland Industries Q2 Sales USD 50.1 Million Vs. IBES Estimate USD 51.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666014537","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666014537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:15","pubTimestamp":1788984917,"startTime":"0","endTime":"0","summary":"Sep 09 (Reuters) - Lakeland Industries Q2 operating expenses USD 20.6 million.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 09-SEP-202620:02:01.12 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nRSD1tZzz8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","LAKE","IE0031619046.USD","IE00B66KJ199.SGD","BK4202","IE00B7SZL793.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370865","title":"Lakeland Industries Q2 Net Sales Fall on Industrial Revenue Decline Despite Fire Products Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370865","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370865?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:13","pubTimestamp":1788984835,"startTime":"0","endTime":"0","summary":"Lakeland Industries Q2 net sales fall on industrial revenue decline despite fire products demandOverviewUS protective apparel maker's fiscal Q2 sales fell 4.5% yr/yr, missing analyst expectationsAdjus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N45112E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LAKE","IE00B19Z4B17.USD","BK4202","IE0031619046.USD","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537469","title":"Lakeland Industries Shares Down 8% After the Bell Following Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537469","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537469?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:05","pubTimestamp":1788984304,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL6N4511BD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LAKE","IE00B19Z4B17.USD","IE00B7SZL793.SGD","IE0031619046.USD","BK4202","BK4568","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371965","title":"Lakeland Industries Q2 EPS $(0.50) Misses $(0.05) Estimate, Sales $50.139M Miss $51.483M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371965","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371965?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984111,"startTime":"0","endTime":"0","summary":"Lakeland Industries (NASDAQ:LAKE) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.05) by 900 percent. This is a 725 percent decrease over earnings of $0.08 per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/09/61700129/lakeland-industries-q2-eps-0-50-misses-0-05-estimate-sales-50-139m-miss-51-483m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Lakeland Industries Q2 EPS $(0.50) Misses $(0.05) Estimate, Sales $50.139M Miss $51.483M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LAKE","IE00B19Z4B17.USD","BK4568","IE00B66KJ199.SGD","IE0031619046.USD","IE00B7SZL793.SGD","BK4202"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537118","title":"Lakeland Q2 FY27 Net Loss Widens to $4.9 Million; Net Sales Fall 4.5% to $50.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537118","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537118?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984107,"startTime":"0","endTime":"0","summary":"Lakeland Q2 FY27 net loss widens to $4.9 million; net sales fall 4.5% to $50.1 millionLakeland Industries posted Q2 FY2027 net loss of USD 4.9 million, turning from profit, on net sales down 4.5% to U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDLbq9rgm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BQXX3F31.USD","BK4588","BK4112","BK4568","BCDF","IE00B64PRP62.GBP","SG9999014013.SGD","LU2210150020.SGD","IE00BKPKM429.USD","LU2095319765.USD","IE00B66KJ199.SGD","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","IE00B19Z4B17.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014039.USD","LAKE","SG9999014005.SGD","IE0031619046.USD","IE00BN0W2V16.EUR","BK4202","IE00BQXX3D17.EUR","NDAQ","SG9999014021.USD","IE00B7SZL793.SGD","IE00B3QW5Z07.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253716","title":"Lakeland Industries Q2 Gross Profit USD 18.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253716?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984061,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nPLXQ8F5PN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LAKE","IE00B7SZL793.SGD","IE0031619046.USD","IE00B66KJ199.SGD","BK4202","IE00B19Z4B17.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537167","title":"Lakeland Fire + Safety Reports Fiscal Second Quarter 2027 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537167","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537167?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984061,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUACBQV6D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B66KJ199.SGD","BK4568","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4202","LAKE","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666375495","title":"U.S. Earnings Preview: After Market Close Sept. 9","url":"https://stock-news.laohu8.com/highlight/detail?id=2666375495","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666375495?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:30","pubTimestamp":1788982200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the marke","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","BK4177","BK4187","BK4189","BK4532","BK4603","LAKE","IE00B19Z4B17.USD","BK4202","BK4094","DRNZ","BK4568","IE00B66KJ199.SGD","AVXX","LMNR","FIZZ","AEO","AVAV","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666329645","title":"Opus Genetics price target raised to $16 from $13 at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666329645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666329645?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:40","pubTimestamp":1788975649,"startTime":"0","endTime":"0","summary":"Chardan analyst Andreas Argyrides raised the firm’s price target on Opus Genetics (IRD) to $16 from $13 and keeps a Buy rating on the shares follow...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opus-genetics-price-target-raised-to-16-from-13-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opus-genetics-price-target-raised-to-16-from-13-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4585","BK4588","BNTX","BK4139","BK4007","IRD","BK4568","BK4548","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532336","title":"TwoStep Therapeutics Raises $62.5 Million in Series a Led by Insight Partners, Medical Excellence Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532336","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666532336?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:38","pubTimestamp":1788975520,"startTime":"0","endTime":"0","summary":"TwoStep Therapeutics raises $62.5 million in Series A led by Insight Partners, Medical Excellence CapitalTwoStep Therapeutics raised a USD 62.5 million oversubscribed Series A led by Insight Partners,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL44Fpct:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0170899867.USD","BK4588","LU1057294990.SGD","BK4007","SG9999011175.SGD","BK4534","IE00B19Z3B42.SGD","LU2596442595.SGD","BK4568","BK4533","SG9999003800.SGD","LU0289739699.SGD","SGXZ57979304.SGD","LU1894683264.USD","LU0058720904.USD","LU0234572021.USD","BK4550","PFE","SG9999002232.USD","SG9999001176.SGD","LU0456855351.SGD","LU1066053197.SGD","IE0002270589.USD","LU1066051498.USD","LU0868494617.USD","BK4581","IE00BLSP4239.USD","LU0321505439.SGD","LU0985481810.HKD","IE000M9KFDE8.USD","LU1894683348.USD","IE00B19Z3581.USD","BK4592","IE00BLSP4452.SGD","LU0122379950.USD","IE00BBT3K403.USD","LU0321505868.SGD","SG9999002224.SGD","IE00B3T34201.USD","SG9999013999.USD","LU1023059063.AUD","SG9999001176.USD","LU0225284248.USD","LU0225771236.USD","BK4585","OZEM","LU0306806265.USD","LU1883839398.USD","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311265","title":"Moderna Set for 3 Near-Term INT Data Readouts, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311265","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311265?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:58","pubTimestamp":1788969505,"startTime":"0","endTime":"0","summary":"Moderna  is set for three data readouts on its individualized neoantigen therapies, or INT, in the near term, serving as potential stock catalysts for the company, UBS Securities said in a Tuesday note.The next major catalyst is the release of phase 3 data on melanoma at an international conference this fall, investors awaiting efficacy on recurrence-free survival and distant metastasis-free survival, the brokerage said.Likely to follow is the phase 2 data on either renal cell carcinoma or muscle-invasive bladder cancer, potentially in 2027, according to UBS. The next readout is probably a phase 3 update on adjuvant non-small cell lung cancer, the investment firm added.UBS has a neutral rating and $150 price target on Moderna.Price: 137.50, Change: -2.83, Percent Change: -2.02","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","IDNA","MRNY","WDNA","BK4548","BK4534","BK4568","BK4532","BK4501","BK4588","GNOM","MRNA","BK4533","BK4139","LGHT","BK4551","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666362775","title":"AstraZeneca Shares Look Set for Swift Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2666362775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666362775?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:01","pubTimestamp":1788962460,"startTime":"0","endTime":"0","summary":"1401 GMT - AstraZeneca shares have been overly punished by recent concerns, but they look set for a swift recovery once uncertainty dissipates, RBC Capital Markets analysts say in a research note. The failure of a heart-disease clinical trial, takeover speculation and uncertainty about upcoming results from two big cancer studies have all weighed on the U.K. drugmaker's stock, the analysts say. AstraZeneca faces low expectations for the two late-stage trials in breast and lung cancers and it doesn't need them to be successful to reach its target of $80 billion in revenue by 2030, but uncertainty might keep risk-averse investors on the sidelines, they add. RBC starts coverage of AstraZeneca with an outperform recommendation and a target price of 145 pounds. Shares fall 1.7% to 116.82 pounds.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU2456880835.USD","LU2417539215.USD","BK4568","BK4588","LU0128525929.USD","LU0310800379.SGD","BK4007","BK4585","AZNH","IE00B3T34201.USD","LU2237443978.SGD","LU0058720904.USD","LU0889565916.HKD","LU2462157665.USD","LU0432979614.USD","LU2237443465.HKD","LU2468319806.SGD","LU2237443622.USD","LU2236285917.USD","LU0109394709.USD","LU2237443549.SGD","LU1267930573.SGD","LU0708994859.HKD","LU0289739699.SGD","LU1829250122.USD","AZN","LU0029864427.USD","LU0320765992.SGD","LU2237443895.HKD","LU2237443382.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666872533","title":"AstraZeneca's COPD Drug Data to Boost Sales Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2666872533","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666872533?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:29","pubTimestamp":1788956940,"startTime":"0","endTime":"0","summary":"1228 GMT - AstraZeneca reported blowout data for its new chronic obstructive pulmonary disease drug, which support sales expectations sharply above current consensus estimates, Citi analysts say in a research note. Full study results from the U.K. pharmaceutical company for its tozorakimab point to potential for a broad use across all populations of COPD patients, the analysts say. Tozorakimab also achieved better data for the subgroup of patients for which Sanofi and Regeneron's Dupixent and GSK's Nucala are approved, they add. As a result, Citi says the data support potential peak sales for tozorakimab of at least its estimate of $7 billion, or roughly double what the current consensus estimate for the drug projects. AstraZeneca shares fall 1.1%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AstraZeneca's COPD Drug Data to Boost Sales Outlook","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3T34201.USD","LU0128525929.USD","LU0310800379.SGD","LU1267930573.SGD","LU0889565916.HKD","LU0029864427.USD","LU0432979614.USD","BK4007","BK4568","LU2089984988.USD","BK4585","LU2237443622.USD","LU2237443895.HKD","LU2237443549.SGD","LU2468319806.SGD","LU0109394709.USD","LU0708994859.HKD","LU0320765992.SGD","AZN","LU2237443382.USD","LU2417539215.USD","AZNH","LU0058720904.USD","LU2456880835.USD","LU2237443465.HKD","LU1829250122.USD","LU2236285917.USD","LU2237443978.SGD","LU0289739699.SGD","BK4588","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666842995","title":"RBC Initiates AstraZeneca at Outperform With GBP145 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666842995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666842995?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:23","pubTimestamp":1788949437,"startTime":"0","endTime":"0","summary":"AstraZeneca's (AZN) London stock has an average rating of buy and mean price target of GBP160.21, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2456880835.USD","LU0058720904.USD","LU0029864427.USD","LU0708994859.HKD","LU2237443382.USD","LU0889565916.HKD","AZN","LU2468319806.SGD","BK4585","LU1267930573.SGD","LU0432979614.USD","LU2236285917.USD","LU1829250122.USD","LU0109394709.USD","LU0320765992.SGD","BK4588","IE00B3T34201.USD","LU2237443978.SGD","LU2237443895.HKD","BK4007","LU2417539215.USD","AZNH","LU2237443622.USD","LU0310800379.SGD","BK4568","LU0128525929.USD","LU2237443549.SGD","LU2237443465.HKD","LU2462157665.USD","LU2089984988.USD","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666589690","title":"BMO Capital Adjusts Price Target on Pfizer to $35 From $30, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666589690","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666589690?lang=en_us&edition=fundamental","pubTime":"2026-09-09 17:19","pubTimestamp":1788945566,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) has an average rating of hold and mean price target of $28.49, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985481810.HKD","LU1066053197.SGD","IE00B19Z3581.USD","BK4581","SG9999001176.SGD","LU2596442595.SGD","SG9999002224.SGD","LU0306806265.USD","LU1894683264.USD","LU0868494617.USD","BK4592","LU0225284248.USD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","BK4007","IE00BLSP4239.USD","LU0225771236.USD","LU1057294990.SGD","PFE","SG9999011175.SGD","LU1066051498.USD","SG9999001176.USD","BK4599","OZEM","LU0306807586.USD","BK4533","LU1894683348.USD","LU0058720904.USD","BK4534","LU0234572021.USD","LU1023059063.AUD","LU1883839398.USD","LU0321505439.SGD","BK4585","LU0456855351.SGD","BK4550","IE00BLSP4452.SGD","SG9999003800.SGD","LU0122379950.USD","BK4568","SG9999013999.USD","IE000M9KFDE8.USD","IE00B3T34201.USD","LU0170899867.USD","LU0289739699.SGD","SG9999002232.USD","LU0321505868.SGD","IE0002270589.USD","SGXZ57979304.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666308355","title":"Ocugen to Share Ophthalmic Gene Therapy Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666308355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666308355?lang=en_us&edition=fundamental","pubTime":"2026-09-09 06:09","pubTimestamp":1788905392,"startTime":"0","endTime":"0","summary":"Ocugen ( ($OCGN) ) has shared an update. On September 8, 2026, Ocugen said it would publish an investor presentation outlining progress across its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocugen-to-share-ophthalmic-gene-therapy-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocugen-to-share-ophthalmic-gene-therapy-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4097","BK4568","BK4563","LU2065732104.USD","PRGS","OCGN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":209,"code":"91000000","status":"200"}]}}